In Hong Kong, cervical cancer is the seventh commonest cancer among females and accounts for about 3.6% of all new cancer cases. To reduce the disease burden, a cervical cancer screening programme was launched in 2004 and two vaccines were introduced in 2006. However, HPV vaccination is not included in the government immunisation schedule and is largely taken up in private clinics opportunistically. The uptake rate of HPV vaccination among adolescent girls in Hong Kong is low (2.1%-9.1%).1,2 The success of a HPV vaccination programme largely depends on the local stakeholders’ attitude towards risks and benefits of vaccination. Our study used a discrete choice experiment to elicit Hong Kong mothers’ preference and willingness ...
The present study is aimed at assessing the feasibility of delivering the HPV (human papillomavirus)...
Objectives: To explore perceptions towards cervical cancer, human papillomavirus (HPV) infection and...
© 2016 by the authors; licensee MDPI, Basel, Switzerland. The Human Papillomavirus (HPV) vaccine ha...
In Hong Kong, cervical cancer is the seventh commonest cancer among females and accounts for about...
Objectives: To determine the preference of mothers in Hong Kong and their willingness to pay (WTP) f...
OBJECTIVES: To determine the preference of mothers in Hong Kong and their willingness to pay (WTP) ...
BACKGROUND: Organized population-based HPV vaccination programs can be effective in reducing the bur...
Background: To generate knowledge about potential improvements to human papillomavirus (HPV) vaccina...
Background: Cervical cancer is one of the common cancers among women worldwide. Despite HPV vaccinat...
A discrete choice experiment was developed to investigate if girls aged 12¿16 years make trade-offs ...
A discrete choice experiment was developed to investigate if girls aged 12–16 years make trade-offs ...
Background: The Human Papilloma Virus (HPV) vaccination provides substantial protection, and it is b...
<div><p>The present study is aimed at assessing the feasibility of delivering the HPV (human papillo...
Objective: Mothers play a significant role in decision making about human papillomavirus (HPV) vacci...
Objectives: To systematically review, appraise and evaluate available evidence regarding discrete-ch...
The present study is aimed at assessing the feasibility of delivering the HPV (human papillomavirus)...
Objectives: To explore perceptions towards cervical cancer, human papillomavirus (HPV) infection and...
© 2016 by the authors; licensee MDPI, Basel, Switzerland. The Human Papillomavirus (HPV) vaccine ha...
In Hong Kong, cervical cancer is the seventh commonest cancer among females and accounts for about...
Objectives: To determine the preference of mothers in Hong Kong and their willingness to pay (WTP) f...
OBJECTIVES: To determine the preference of mothers in Hong Kong and their willingness to pay (WTP) ...
BACKGROUND: Organized population-based HPV vaccination programs can be effective in reducing the bur...
Background: To generate knowledge about potential improvements to human papillomavirus (HPV) vaccina...
Background: Cervical cancer is one of the common cancers among women worldwide. Despite HPV vaccinat...
A discrete choice experiment was developed to investigate if girls aged 12¿16 years make trade-offs ...
A discrete choice experiment was developed to investigate if girls aged 12–16 years make trade-offs ...
Background: The Human Papilloma Virus (HPV) vaccination provides substantial protection, and it is b...
<div><p>The present study is aimed at assessing the feasibility of delivering the HPV (human papillo...
Objective: Mothers play a significant role in decision making about human papillomavirus (HPV) vacci...
Objectives: To systematically review, appraise and evaluate available evidence regarding discrete-ch...
The present study is aimed at assessing the feasibility of delivering the HPV (human papillomavirus)...
Objectives: To explore perceptions towards cervical cancer, human papillomavirus (HPV) infection and...
© 2016 by the authors; licensee MDPI, Basel, Switzerland. The Human Papillomavirus (HPV) vaccine ha...